Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Key value for chemical safety assessment

Genetic toxicity in vitro

Description of key information

Gene mutation toxicity study was performed to determine the mutagenic nature of Pyrrolidinoethyl chloride. The study was performed using the modified Ames assay using eight histidine auxotrophs of Salmonella typhimurium (G46, TA1535, TA100, C3076, TA1537, D3052, TA1538, and TA98) and two tryptophan auxotraphs of Escherichia coli (WP2 and WP2 uvrA-) with and without S9 metabolic activation system. The inocula of ten bacterial tester strains were streaked across square agar plates containing a concentration gradient of test compound and mutagenicity was scored by noting the number of tester strains showing mutant colonies over a given concentration range. The test compound was incorporated into four gradient plates to give a tenfold concentration range per plate, thus providing a 10,000-fold concentration range for the test. Pyrrolidinoethyl chloride induced gene mutation in Salmonella typhimurium strains G46, TA1535, TA100 and E. coli strain WP2 uvrA without metabolic activation system at a minimum mutagenic concentration of 0.6 nanomoles/mL. It however failed to induce gene mutation in Salmonella typhimurium (C3076, TA1537, D3052, TA1538, and TA98) and Escherichia coli (WP2) in the presence and absence of S9 metabolic activation system.

Link to relevant study records
Reference
Endpoint:
in vitro gene mutation study in bacteria
Remarks:
Type of genotoxicity: gene mutation
Type of information:
experimental study
Adequacy of study:
supporting study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
data from handbook or collection of data
Justification for type of information:
Data is from peer reviwed journal
Qualifier:
according to guideline
Guideline:
other: Refer below principle
Principles of method if other than guideline:
In vitro gene toxicity study was performed by the gradient plate test to determine the mutagenic nature of Pyrrolidinoethyl chloride in Salmonella typhimurium and E coli
GLP compliance:
not specified
Type of assay:
bacterial gene mutation assay
Specific details on test material used for the study:
- Name of test material: Pyrrolidinoethyl chloride
- IUPAC name: 1-(2-chloroethyl)pyrrolidine hydrochloride
- Molecular formula: C8H9Cl3O
- Molecular weight: 227.517 g/mol
- Substance type: organic
- Physical state: No data available
- Purity :No data available
- Impurities (identity and concentrations): No data available
Target gene:
Histidine for Salmonella typhimurium strains and tryptophan for E. coli strains
Species / strain / cell type:
S. typhimurium, other: G46, TA1535, TA100, C3076, TA1537, D3052, TA1538, and TA98
Details on mammalian cell type (if applicable):
Not applicable
Additional strain / cell type characteristics:
other: Histidine auxotrophs
Species / strain / cell type:
E. coli, other: WP2 and WP2uvrA-
Details on mammalian cell type (if applicable):
Not applicable
Additional strain / cell type characteristics:
other: Histidine auxotrophs
Cytokinesis block (if used):
No data
Metabolic activation:
without
Metabolic activation system:
Liver activating system
Test concentrations with justification for top dose:
The highest compound concentration tested was 1,000 mcg/ml of agar (Strain G46: 500-1000, TA1535: 100-1000, TA100: 1-1000, WP2: 0.1-300, WP2uvrA-: 0.1-50 mcg/mL)
Vehicle / solvent:
- Vehicle(s)/solvent(s) used: Sterile distilled water
- Justification for choice of solvent/vehicle: The chemical was soluble in sterile distilled water
Untreated negative controls:
not specified
Negative solvent / vehicle controls:
yes
Remarks:
Sterile distilled water
True negative controls:
not specified
Positive controls:
not specified
Positive control substance:
not specified
Details on test system and experimental conditions:
METHOD OF APPLICATION: in agar
- Cell density at seeding (if applicable): No data

DURATION
- Preincubation period: No data
- Exposure duration: No data
- Expression time (cells in growth medium): No data
- Selection time (if incubation with a selection agent): No data
- Fixation time (start of exposure up to fixation or harvest of cells): No data

SELECTION AGENT (mutation assays): No data

SPINDLE INHIBITOR (cytogenetic assays): No data

STAIN (for cytogenetic assays): No data

NUMBER OF REPLICATIONS: No data

METHODS OF SLIDE PREPARATION AND STAINING TECHNIQUE USED: No data

NUMBER OF CELLS EVALUATED: No data

NUMBER OF METAPHASE SPREADS ANALYSED PER DOSE (if in vitro cytogenicity study in mammalian cells): No data

CRITERIA FOR MICRONUCLEUS IDENTIFICATION: No data

DETERMINATION OF CYTOTOXICITY
- Method: mitotic index; cloning efficiency; relative total growth; other: No data
- Any supplementary information relevant to cytotoxicity: No data

OTHER EXAMINATIONS:
- Determination of polyploidy: No data
- Determination of endoreplication: No data
- Methods, such as kinetochore antibody binding, to characterize whether micronuclei contain whole or fragmented chromosomes (if applicable): No data

- OTHER: No data
Rationale for test conditions:
No data
Evaluation criteria:
The chemical Pyrrolidinoethyl chloride was screened for its ability to produce an increase in revertants in any of the strains used for the study
Statistics:
No data available
Species / strain:
S. typhimurium, other: C3076, TA1537, D3052, TA1538, and TA98
Metabolic activation:
without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
not specified
Vehicle controls validity:
valid
Untreated negative controls validity:
not specified
Positive controls validity:
not specified
Species / strain:
S. typhimurium, other: G46, TA1535, TA100
Metabolic activation:
without
Genotoxicity:
positive
Cytotoxicity / choice of top concentrations:
not specified
Vehicle controls validity:
valid
Untreated negative controls validity:
not specified
Positive controls validity:
not specified
Species / strain:
E. coli, other: WP2 and WP2uvrA-
Metabolic activation:
without
Genotoxicity:
positive
Cytotoxicity / choice of top concentrations:
not specified
Vehicle controls validity:
valid
Untreated negative controls validity:
not specified
Positive controls validity:
not specified
Additional information on results:
No data
Conclusions:
Pyrrolidinoethyl chloride did not induce an increase in the number of revertants in Salmonella typhimurium strains C3076, TA1537, D3052, TA1538, and TA98 in the absence of liver activating enzymes. It however induced an increase in the number of revertants in Salmonella typhimurium strains G46, TA1535, TA100 and E. coli strains WP2 and WP2uvrA- in the absence of liver activating enzymes.




in the concentration of 1 to 1,000 mcg/ml /plate and 0.1 to 300.0 mcg/ml show bacterial cell mutation toxicity when Salmonella typhimurium (G46, TA1535, TA100) and E coli (WP2 and WP2uvrA-) cells were exposed to the test chemical.

Executive summary:

In vitro gene toxicity study was performed to determine the mutagenic nature of Pyrrolidinoethyl chloride using Salmonella typhimurium strains G46, TA1535, TA100, C3076, TA1537, D3052, TA1538, and TA98 and E. coli strains WP2 and WP2uvrA-. Bacterial mutagenesis was performed by the gradient plate test. Pyrrolidinoethyl chloride was incorporated into the top layer of agar on four 10- X 10-cm square plates to give a tenfold concentration gradient per plate, thus providing a 10,000-fold concentration range. The highest compound concentration tested was 1,000 mcg/ml of agar ( Strain G46: 500-1000, TA1535: 100-1000, TA100: 1-1000, WP2: 0.1-300, WP2uvrA-: 0.1-50 mcg/mL). Since Pyrrolidinoethyl chloride is a direct acting alkylating agent, the assay was performed in the absence of liver activating system. The chemical was screened for its ability to produce an increase in revertants in any of the strains used for the study. Pyrrolidinoethyl chloride did not induce an increase in the number of revertants in Salmonella typhimurium strains C3076, TA1537, D3052, TA1538, and TA98 in the absence of liver activating enzymes. It however induced an increase in the number of revertants in Salmonella typhimurium strains G46 (500 -1000 mcg/mL), TA1535 (100 -1000 mcg/mL), TA100 (1 -1000 mcg/mL) and E. coli strains WP2 (1.0 -300.0 mcg/mL) and WP2uvrA- (0.1- 50.0 mcg/mL) in the absence of liver activating enzymes.

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (negative)

Genetic toxicity in vivo

Endpoint conclusion
Endpoint conclusion:
no study available

Additional information

Gene mutation in vitro:

Variuos peer reviewed publications were reviewed to determine the mutagenic nature of Pyrrolidinoethyl chloride. The studies are as mentioned below:

Gene mutation toxicity study was performed by Probst et al ( Environmental Mutagenesis, 1981) to determine the mutagenic nature of Pyrrolidinoethyl chloride. The study was performed using the modified Ames assay using eight histidine auxotrophs of Salmonella typhimurium (G46, TA1535, TA100, C3076, TA1537, D3052, TA1538, and TA98) and two tryptophan auxotraphs of Escherichia coli (WP2 and WP2 uvrA-) with and without S9 metabolic activation system. The inocula of ten bacterial tester strains were streaked across square agar plates containing a concentration gradient of test compound and mutagenicity was scored by noting the number of tester strains showing mutant colonies over a given concentration range. The test compound was incorporated into four gradient plates to give a tenfold concentration range per plate, thus providing a 10,000-fold concentration range for the test. Pyrrolidinoethyl chloride induced gene mutation in Salmonella typhimurium strains G46, TA1535, TA100 and E. coli strain WP2 uvrA without metabolic activation system at a minimum mutagenic concentration of 0.6 nanomoles/mL. It however failed to induce gene mutation in Salmonella typhimurium (C3076, TA1537, D3052, TA1538, and TA98) and Escherichia coli (WP2) in the presence and absence of S9 metabolic activation system.

Thompson et al (Environmental mutagenesis, 1981) performed in vitro gene toxicity study to determine the mutagenic nature of Pyrrolidinoethyl chloride using Salmonella typhimurium strains G46, TA1535, TA100, C3076, TA1537, D3052, TA1538, and TA98 and E. coli strains WP2 and WP2uvrA-. Bacterial mutagenesis was performed by the gradient plate test. Pyrrolidinoethyl chloride was incorporated into the top layer of agar on four 10- X 10-cm square plates to give a tenfold concentration gradient per plate, thus providing a 10,000-fold concentration range. The highest compound concentration tested was 1,000 mcg/ml of agar ( Strain G46: 500-1000, TA1535: 100-1000, TA100: 1-1000, WP2: 0.1-300, WP2uvrA-: 0.1-50 mcg/mL). Since Pyrrolidinoethyl chloride is a direct acting alkylating agent, the assay was performed in the absence of liver activating system. The chemical was screened for its ability to produce an increase in revertants in any of the strains used for the study. Pyrrolidinoethyl chloride did not induce an increase in the number of revertants in Salmonella typhimurium strains C3076, TA1537, D3052, TA1538, and TA98 in the absence of liver activating enzymes. It however induced an increase in the number of revertants in Salmonella typhimurium strains G46 (500 -1000 mcg/mL), TA1535 (100 -1000 mcg/mL), TA100 (1 -1000 mcg/mL) and E. coli strains WP2 (1.0 -300.0 mcg/mL) and WP2uvrA- (0.1- 50.0 mcg/mL) in the absence of liver activating enzymes.

In the same study mentioned by Thompson et al, In vitro gene toxicity study was performed by Ames assay to determine the mutagenic nature of Pyrrolidinoethyl chloride in Salmonella typhimurium and E coli. The study was performed using Salmenella typhimurium strains TA1535 and TA100 and E. coli strains WP2 and WP2 uvrA-. The highest concentration for the study was 1800 µM /plate. The chemical was screened for its ability to produce an increase in revertants in any of the strains used for the study. Pyrrolidinoethyl chloride induced an increase in the number of revertants in Salmonella typhimurium strains TA1535, TA100 and E. coli strains WP2 and WP2uvrA- and hence is likely to be mutagenic in vitro.

Another study was also mentioned by Thomson et al, In vitro gene toxicity study was performed for Pyrrolidinoethyl chloride in mouse lymphoma cells using Mouse Lymphoma Cell Forward Mutation Assay. The assay procedure used was patterned as that mentioned by Clive et al and employed the modifications described by Amacher et al. Pyrrolidinoethyl chloride was evaluated for its potential to increase the rate of mutation at the thymidine kinase locus scored as trifluorothymidine (TFT) resistance. The test chemical was dissolved using sterile distilled water and used at a concentration from 0,11, 22, 44, 88, 176 nanomoles/mL. Pyrrolidinoethyl chloride induced an increase in the rate of mutation at the thymidine kinase locus when L5178Y Mouse Lymphoma Cell  were exposed to the test chemical and hence is positive for gene mutation in vitro.

Based on the available data for the target chemical, Pyrrolidinoethyl chloride (CAS no 7250 -67 -1) is not likely to exhibit gene mutation in vitro. Though positive effect has been shown by the test chemical as discussed in the some of the studies but the clarity on the use of exogeneous metabolic activation system is unknown. Due to lack of clarity of the studies, the positive effect is not taken into consideretion for classification. Hence, on the basis of the key study and its supporting data, the chemical is not likely to be classified as a gene mutant in vitro.

Justification for classification or non-classification

Based on the available data for the target chemical, Pyrrolidinoethyl chloride (CAS no 7250 -67 -1) is not likely to exhibit gene mutation in vitro. Hence the chemical is not likely to be classified as a gene mutant in vitro.